000 01485 a2200385 4500
005 20250513085040.0
264 0 _c19960319
008 199603s 0 0 eng d
022 _a1042-8194
024 7 _a10.3109/10428199509064931
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMyers, D E
245 0 0 _aAn anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cJun 1995
300 _a119-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xchemistry
650 0 4 _aAntigens, CD
_xchemistry
650 0 4 _aAntigens, Differentiation, B-Lymphocyte
_xchemistry
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aBurkitt Lymphoma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunotoxins
_xchemistry
650 0 4 _aLeukemia, Lymphoid
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aN-Glycosyl Hydrolases
650 0 4 _aPlant Proteins
_xpharmacology
650 0 4 _aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aRibosome Inactivating Proteins, Type 1
700 1 _aUckun, F M
773 0 _tLeukemia & lymphoma
_gvol. 18
_gno. 1-2
_gp. 119-22
856 4 0 _uhttps://doi.org/10.3109/10428199509064931
_zAvailable from publisher's website
999 _c8579872
_d8579872